CorVel Corp

CorVel Corp(CRVL)股票分析

$81.310

+1.618 (+1.99%)收盤時

Loading chart…
最高
81.640
開盤
80.700
成交量加權均價
81.18
成交量
124.34K
市值
4.32B
最低
80.580
成交金額
10.09M
企業價值/稅息折舊攤銷前利潤(TTM)
0.00

CorVel Corporation applies technology, including artificial intelligence, machine learning and natural language processing, to enhance the management of episodes of care and the related health-care costs. The Company partners with employers, third-party administrators, insurance companies and government agencies to assist its customers in managing the medical costs of workers compensation, group health and auto insurance, and in monitoring the quality of care provided to claimants. Its services include claims management, bill review, preferred provider networks, utilization management, case management, pharmacy services, directed care and Medicare services. It delivers its solutions in three ways - as a fully integrated claims-management program, as discrete standalone services, or as targeted add-ons that enhance an existing client workflow. Integrated, end-to-end bundled programs are designed primarily for buyers such as self-insured employers who want a single, turnkey partner.

AI 分析 of CorVel Corp (CRVL)

買進

CorVel Corp is a good buy right now due to its recent strong financial performance, with a Q1 net profit of $32.22 million and an EPS of $0.63, both showing significant year-over-year growth. Additionally, the RSI is at 77.48, indicating strong momentum, while the stock has shown a 21.22% year-to-date increase, reflecting positive market sentiment. The main risk is the high forward P/E of 23.75, suggesting that the stock may be overvalued if growth expectations are not met.

估值指標

CorVel Corp(CRVL)目前預期本益比為 23.75,5 年平均預期本益比為 91.09。

預期本益比

低估
5 年均值 P/E
91.09
目前P/E
23.75
高估
130.81
低估
51.36

預期 EV/EBITDA

嚴重低估
5 年均值 EV/EBITDA
0.00
目前EV/EBITDA
0.00
高估
0.00
低估
0.00

預期股價營收比

嚴重低估
5 年均值 P/S
7.01
目前P/S
0.00
高估
8.94
低估
5.09

持有 CRVL 的大戶

K

Kayne Anderson Rudnick Investment Management, LLC

+ 持有CRVL

-2.31%

3個月報酬率

事件時間軸

2026-06-01 (ET)

16:40:00

CorVel Appoints Sarah Scott as CEO

2026-05-20 (ET)

06:20:00

Q4 Revenue Reaches $248.54M

2026-02-03 (ET)

06:20:00

Q3 Revenue Reaches $236M vs. $228M Last Year

2025-02-13 (ET)

06:36:59

CorVel appoints Scott as Executive Vice President of Product

2024-12-24 (ET)

12:16:10

CorVel announces effectiveness of three-for-one forward stock split

資訊

CRVL 常見問題 —— 由 Alphio AI 解答

CorVel Corporation applies technology, including artificial intelligence, machine learning and natural language processing, to enhance the management of episodes of care and the related health-care costs. The Company partners with employers, third-party administrators, insurance companies and government agencies to assist its customers in managing the medical costs of workers compensation, group health and auto insurance, and in monitoring the quality of care provided to claimants. Its services include claims management, bill review, preferred provider networks, utilization management, case management, pharmacy services, directed care and Medicare services. It delivers its solutions in three ways - as a fully integrated claims-management program, as discrete standalone services, or as targeted add-ons that enhance an existing client workflow. Integrated, end-to-end bundled programs are designed primarily for buyers such as self-insured employers who want a single, turnkey partner. It operates in the Healthcare sector (INSURANCE AGENTS, BROKERS & SERVICE industry).

CorVel Corp is a good buy right now due to its recent strong financial performance, with a Q1 net profit of $32.22 million and an EPS of $0.63, both showing significant year-over-year growth. Additionally, the RSI is at 77.48, indicating strong momentum, while the stock has shown a 21.22% year-to-date increase, reflecting positive market sentiment. The main risk is the high forward P/E of 23.75, suggesting that the stock may be overvalued if growth expectations are not met.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易